Suppression of adipose lipolysis by long-chain fatty acid analogs

Journal of Lipid Research

Volumn 53, Issue 5, 2012, Pages 868-878

  Kalderon, Bella ^a   Azazmeh, Narmen ^a   Azulay, Nili ^a   Vissler, Noam ^a   Valitsky, Michael ^a   Bar Tana, Jacob ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

AMPK; cAMP; Diabetes; Raf1

Indexed keywords

3,3,14,14 TETRAMETHYLHEXADECANEDIOIC ACID; ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HORMONE SENSITIVE LIPASE; INSULIN; ISOPRENALINE; PERILIPIN; RAF PROTEIN; RAF1 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ESTERIFICATION; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; LIPOLYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNFOLDED PROTEIN RESPONSE;

3T3-L1 CELLS; ADENYLATE CYCLASE; ADIPOSE TISSUE; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FATTY ACIDS; ISOPROTERENOL; LIPOLYSIS; MALE; MAP KINASE KINASE KINASES; MICE; RATS; RATS, WISTAR; RIBONUCLEOSIDES; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

EID: 84860281134     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M022673     Document Type: Article

References (35)

1. Duncan, R. E., M. Ahmadian, K. Jaworski, E. Sarkadi-Nagy, and H. S. Sul. 2007. Regulation of lipolysis in adipocytes. Annu. Rev. Nutr. 27: 79-101. (Pubitemid 351373349)
2. Kitamura, T., Y. Kitamura, S. Kuroda, Y. Hino, M. Ando, K. Kotani, H. Konishi, H. Mtsuzaki, U. Kikkawa, W. Ogawa, et al. 1999. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol. Cell. Biol. 19: 6286-6296. (Pubitemid 29399333)
3. Guilherme, A., J. V. Virbasius, V. Puri, and M. P. Czech. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9: 367-377. (Pubitemid 351574198)
4. Burns, T. W., P. E. Langley, B. E. Terry, and G. A. Robinson. 1978. The role of free fatty acids in the regulation of lipolysis by human adipose tissue cells. Metabolism. 27: 1755-1762. (Pubitemid 9085444)
5. Fain, J. N., and R. E. Shepherd. 1975. Free fatty acids as feedback regulators of adenylate cyclase and cyclic 3′:5′-AMP accumulation in rat fat cells. J. Biol. Chem. 250: 6586-6592.
6. Smith, A. J., B. R. Thompson, M. A. Sanders, and D. A. Bernlohr. 2007. Interaction of the adipocyte fatty acid-binding protein with the hormone-sensitive lipase: regulation by fatty acids and phosphorylation. J. Biol. Chem. 282: 32424-32432. (Pubitemid 350106440)
7. Gauthier, M. S., H. Miyoshi, S. C. Souza, J. M. Cacicedo, A. K. Saha, A. S. Greenberg, and N. B. Ruderman. 2008. AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J. Biol. Chem. 283: 16514-16524.
8. Bar-Tana, J., G. Rose-Kahn, and M. Srebnik. 1985. Inhibition of lipid synthesis by beta beta'-tetramethyl-substituted, C14-C22, alpha, omega-dicarboxylic acids in the rat in vivo. J. Biol. Chem. 260: 8404-8410. (Pubitemid 15249849)
9. Bar-Tana, J., G. Rose-Kahn, B. Frenkel, Z. Shafer, and M. Fainaru. 1988. Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats. J. Lipid Res. 29: 431-441.
10. Mayorek, N., B. Kalderon, E. Itach, and J. Bar-Tana. 1997. Sensitization to insulin induced by beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo. Diabetes. 46: 1958-1964. (Pubitemid 27512080)
11. Russell, J. C., R. M. Amy, S. E. Graham, P. J. Dolphin, G. O. Wood, and J. Bar-Tana. 1995. Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by beta, beta'-tetramethylhexadecanedioic acid (MEDICA 16). Arterioscler. Thromb. Vasc. Biol. 15: 918-923.
12. Za'tara, G., J. Bar-Tana, B. Kalderon, M. Suter, E. Morad, D. Samovski, D. Neumann, and R. Hertz. 2008. AMPK activation by long chain fatty acyl analogs. Biochem. Pharmacol. 76: 1263-1275.
13. Kalderon, B., V. Sheena, S. Shachrur, R. Hertz, and J. Bar-Tana. 2002. Modulation by nutrients and drugs of liver acyl-CoAs analyzed by mass spectrometry. J. Lipid Res. 4 3: 1125-1132. (Pubitemid 34760884)
14. Park, S. Y., H. J. Kim, S. Wang, T. Higashimori, J. Dong, Y. J. Kim, G. Cline, H. Li, M. Prentki, G. I. Shulman, et al. 2005. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. Am. J. Physiol. Endocrinol. Metab. 289: E30-E39. (Pubitemid 40874931)
15. Balla, A., G. Tuymetova, M. Barshishat, M. Geiszt, and T. Balla. 2002. Characterization of type II phosphatidylinositol 4-kinase isoform reveals association of the enzymes with endosomal vesicular compartments. J. Biol. Chem. 277: 20041-20050. (Pubitemid 34967528)
16. Anthony, N. M., M. P. Gaidhu, and R. B. Ceddia. 2009. Regulation of visceral and subcutaneous adipocyte lipolysis by acute AICAR-induced AMPK activation. Obesity (Silver Spring). 17: 1312-1317.
17. Daval, M., F. Diot-Dupuy, R. Bazin, I. Hainault, B. Viollet, S. Vaulont, E. Hajduch, P. Ferrè, and F. Foufelle. 2005. Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes. J. Biol. Chem. 280: 25250-25257. (Pubitemid 40934619)
18. Sullivan, J. E., K. J. Brocklehurst, A. E. Marley, F. Carey, D. Carling, and R. K. Ber. 1994. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 353: 33-36. (Pubitemid 24312538)
19. Hardie, D. G. 2007. AMP-activated protein kinase as a drug target. Annu. Rev. Pharmacol. Toxicol. 47: 185-210.
20. Nakamaru, K., K. Matsumoto, T. Taguchi, M. Suefuji, Y. Murata, M. Igata, J. Kawashima, T. Kondo, H. Motoshima, K. Tsuruzoe, et al. 2005. AICAR, an activator of AMP-activated protein kinase, down regulates the insulin receptor expression in HepG2 cells. Biochem. Biophys. Res. Commun. 328: 449-454. (Pubitemid 40208331)
21. Saitoh, M., K. Nagai, K. Nakagawa, T. Yamamura, S. Yamamoto, and T. Nishizaki. 2004. Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochem. Pharmacol. 67: 2005-2011. (Pubitemid 38591388)
22. Silinsky, E. M., and S. M. Vogel. 1986. The effects of an adenylate cyclase inhibitor on the electrophysiological correlates of neuromuscular transmission in the frog. Br. J. Pharmacol. 88: 799-805.
23. Ribeiro-Neto, F. A., R. Mattera, J. D. Hildebrandt, J. Codina, J. B. Field, L. Birnbaumer, and R. D. Sekura. 1985. ADP-ribosylation of membrane components by pertussis and cholera toxin. Methods Enzymol. 109: 566-572.
24. Beazely, M. A., J. K. Alan, and V. J. Watts. 2005. Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells. Mol. Pharmacol. 67: 250-259. (Pubitemid 40069985)
25. Ding, Q., R. Gros, I. D. Gray, R. Taussig, S. S. Ferguson, and R. D. Feldman. 2004. Raf kinase activation of adenylyl cyclases: isoform-selective regulation. Mol. Pharmacol. 66: 921-928. (Pubitemid 39319464)
26. Feldman, R. D., and R. Gros. 2007. New insights into the regulation of cAMP synthesis beyond GPCR/G protein activation: implications in cardiovascular regulation. Life Sci. 81: 267-271. (Pubitemid 47030574)
27. Cnop, M., M. Igoillo-Esteve, D. A. Cunha, L. Ladriere, and D. L. Eizirik. 2008. An update on lipotoxic endoplasmic reticulum stress in pancreatic beta-cells. Biochem. Soc. Trans. 36: 909-915.
28. Wei, Y., D. Wang, F. Topczewski, and M. J. Pagliassotti. 2006. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. 291: E275-E281. (Pubitemid 44035286)
29. Ozcan, U., E. Yilmaz, L. Ozcan, M. Furuhashi, E. Vaillancourt, R. O. Smith, C. Z. Gorgun, and G. S. Hotamisligil. 2006. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 313: 1137-1140. (Pubitemid 44300242)
30. Yamaguchi, T., N. Omatsu, E. Morimoto, H. Nakashima, K. Ueno, T. Tanaka, K. Satouchi, F. Hirose, and T. Osumi. 2007. CGI-58 facilitates lipolysis on lipid droplets but is not involved in the vesiculation of lipid droplets caused by hormonal stimulation. J. Lipid Res. 48: 1078-1089. (Pubitemid 46708675)
31. Zhang, T., J. He, C. Xu, L. Zu, H. Jiang, S. Pu, X. Guo, and G. Xy. 2009. Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes. J. Mol. Endocrinol. 42: 57-66.
32. Lei, T., W. Xie, J. Han, B. E. Corkey, J. A. Hamilton, and W. Guo. 2004. Medium-chain fatty acids attenuate agonist-stimulated lipolysis, mimicking the effects of starvation. Obes. Res. 12: 599-611. (Pubitemid 41132502)
33. Yin, W., J. Mu, and M. J. Birnbaum. 2003. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes. J. Biol. Chem. 278: 43074-43080. (Pubitemid 37345923)
34. Koh, H. J., M. F. Hirshman, H. He, Y. Li, Y. Manabe, J. A. Balschi, and L. J. Goodyear. 2007. Adrenaline is a critical mediator of acute exercise-induced AMP-activated protein kinase activation in adipocytes. Biochem. J. 403: 473-481. (Pubitemid 46706975)
35. Omar, B., E. Zmuda-Trzebiatowska, V. Manganiello, O. Goransson, and E. Degerman. 2009. Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis. Cell. Signal. 21: 760-766.